Keytruda, an antibody drug used in cancer immunotherapy manufactured by Merck and also known as Pembrolizumab, has been approved by the FDA for treatment of solid tumor cancers. Previously, the drug had only been approved to treat non-small cell lung cancer. This is an important development for certain mesothelioma patients. In a press release, the FDA said that clinical trials showed an effective response rate for 29 percent of patients with mesothelioma and other applicable tumors that displayed high levels of mutation. While there is still no cure for mesothelioma, of those who participated in the trial, half saw a […]
The post Keytruda Approved by FDA for Further Potential Treatments of Mesothelioma appeared first on Mesothelioma Help Cancer Organization.
from Blog – Mesothelioma Help Cancer Organization https://ift.tt/2VEkF0a
via IFTTT
No comments: